alkylating agent and histone deacetylase inhibitor

This page covers all alkylating agent and histone deacetylase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (1)

• Temozolomide + Valproic Acid · University of Göttingen · Oncology
  Temozolomide is an alkylating agent that works by interfering with DNA replication, while Valproic Acid is a histone deacetylase inhibitor that modulates gene expression.

Patent intelligence

• alkylating agent and histone deacetylase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates